Mitesh

From 1 November 2023, the list of medicines covered by the HRT prepayment certificate (HRT PPC) will be updated to include a new brand of progesterone micronised capsules, Gepretix®. Part XVI of the November 2023 Drug Tariff will be updated to include the following new HRT medicine for which patients will be able to purchase an [...]

The post Gepretix® added to the HRT PPC medicines list from November 2023 appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 3 October 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age MedSafetyWeek November 2023: your Yellow Card report helps [...]

The post MHRA Drug Safety Update: October 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen at 23.59pm on Friday 27 October 2023. After this [...]

The post Expiry of SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Zinacef powder for solution for injection or infusion vials (all strengths, including stock in GSK livery) (Sandoz Limited) Drug alert number:EL (23)A/38 Date issued: 23 October 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zinacef powder for solution for [...]

The post Class 4 Medicines Defect Information: Zinacef powder for solution for injection or infusion vials (Sandoz Limited) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/10/2023) announced the following list of price concessions for October 2023: Drug Pack Size Price Concession Aciclovir 800mg tablets 35 £3.60 Atorvastatin 80mg tablets 28 £5.22 Benzoyl peroxide 5% / Clindamycin [...]

The post October 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.